• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Drug deliver by utilization of tissue specific transportes.

Research Project

Project/Area Number 10470510
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionKANAZAWA UNIVERSITY

Principal Investigator

TSUJI Akira  Kanazawa University, Pharmacy, Professor, 薬学部, 教授 (10019664)

Co-Investigator(Kenkyū-buntansha) TAMAI Ikumi  Kanazawa University, Graduate School, Associate Professor, 自然科学研究科, 助教授 (20155237)
Project Period (FY) 1998 – 1999
Keywordstransporter / pharmacokinetics / drug delivery / organic cation / monocarboxylic acid / P-glycoprotein / Blood-brain barrier / Carnitine
Research Abstract

Various transporters that mediate membrane transport of drugs as well as physiological compounds were clarified by molecular cloning of the genes and their functional analysis by gene expression systems. The obtained results are as follows :
1. Novel transporter family OCTNs were molecularly cloned and their transport functions were analyzed by transfection of the gene to HEK293 cells. Human and mouse OCTN2 transported physiologically important carnitine in a sodium dependent manner. JVS mice that show systemic carnitine deficiency(SCD) syndrome had a mutation in OCTN2 gene with loss of carnitine transport function. Furthermore, various mutations in OCTN2 gene were identified in patients who show the SCD syndrome. From these results, it was clarified that OCTN2 is a physiologically important camitine transporter and its mutation leads to the SCD. Interestingly, OCTN2 and its isoform OCTN1 transported organic cations in a sodium independent manner. Accordingly, OCTNs are unique transporters which have are multifunctionality by transporting carnitine and organic cations in the distinct mechanisms.
2. Molecular characterization of the transporter for monocarboxylic acids at the blood-brain barrier (BBB) was performed. Monocarboxylic acid transporter MCT-1 gene was expressed at the BBB and was found to play important role in the transport of organic weak acids by the in vitro cultured cells and in vivo studies.
3. Multiple efflux mechanisms for new quinolone antibacterial agent were found to be expressed at the BBB. They are P-glycoprotein and unknown transporters sensitive to anionic compounds. These multiple efflux transporters seem to restrict the brain distribution of quinolones and other drugs, resulting in a low distribution into the central nervous system.
These lines of studies provide new insight of the siginificance of membrane transporters and new strategy to control disposition of drugs by focusing on the transporters function present in various tissues.

  • Research Products

    (36 results)

All Other

All Publications (36 results)

  • [Publications] J. Nezu: "Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter"Nature Genet. 21. 91-94 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K. Yokogawa: "Decreased tissue distribution of L-carnitine in juvenile visceral sieatosis mice"J. Pharmacol. Exp. Ther.. 289. 224-230 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Yabuuchi: "Novel membrane transporter OCTN1 mediates multispecific, bidirectional and pH-dependent transport of organic cations"J. Pharmacol. Exp. Ther.. 289. 768-773 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K. Yokogawa: "Characteristics of L-carnitine transport in cultured hepatoma HLF cells from man"J. Pharm Pharmcol. 51. 935-940 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K. Yokogawa: "Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice"Hepatology. 30. 997-1001 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] R. Ohashi: "Nat-dependent carnitine transport by OCTN2 and its pharmacological and toxicological relevance"J. Pharmacol. Exp. Ther. 291. 778-784 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A. Koizumi: "Genetic epidemiology on carnitine transporter OCTN2 gene in a Japanese population and phenotype characterizations in Japanese pedigrees with primary systemic carnitine deficiency"Human Molecular Genetics. 8. 2247-2254 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M. Murata: "Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent"J. Pharmacol. Exp. Ther.. 289. 79-84 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Sasabe: "Differences in the hepatobililary transport of two quinolone antibiotics, grepufloxacin and lomefloxacin, in the rat"Baiopharm. Drug Dispos. 20. 151-158 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M. Murata: "Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier"J. Pharmacol. Exp. Ther.. 290. 51-57 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M. Kawahara: "Physiologically based phrmacokinetics of digoxin in mdrla knockout mine"J. Pharm. Sci.. 88. 1281-1287 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K. Yokogawa: "P-Glycoprotein-dependent disposition kinetics of tacrolimus : Studies in mdrla knockout mice"Pharm. Res.. 16. 1213-1218 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y. Kido: "Functional clarification of HCT1-mediated transport of monocarboxylic acids at the blood-brain barrier of rats using in vitro cultured in vivo BUI studies"Pharm. Res.. 17. 55-62 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T. Hirohashi: "The function and expression of multidrug resistance-associated protein (MRP) family in human colon odenocarcinoma cells (Caco-2)"J. Pharmacol. Exp. Ther.. 292. 265-270 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A. Tsuji: "An introduction to the blood-brain barrier"Cambridge University Press. (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A. Tsuji: "Membrane transporters as drug targets"Kluwer Academic/Plenum Publications. (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N. Hashimoto, F. Suzuki, I. Tamai, H. Nikaido, M. Kuwajima, J. Hayakawa and A. Tsuji.: "Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency."Biochem. Pharmacol.. 55. 1729-1732 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] I. Tamai, R. Ohashi, J. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai and A. Tsuji.: "Molesular and funcrional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2."J. Biol. Chem.. 273. 20378-20382 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Yabuuchi, I. Tamai, K. Morita, T. Kouda, K. Miyamoto, E. Takeda and A. Tsuji: "Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter Npt1."J. Pharmacol. Exp. Ther.. 286. 1391-1396 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Sasabe, A. Tsuji and Y. Sugiyama.: "Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats."J. Pharmacol. Exp. Ther.. 284. 1033-1039 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Murata, I. Tamai, Y. Sai, O. Nagata, H. Kato, Y. Sugiyama and A. Tsuji.: "Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent."Drug Metab. Dispos.. 26. 1113-1119 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Kawahara, T. Nanbo and A. Tsuji.: "Physiologically based pharmacokinetic prediction of p-phenylbenzoic acid disposition in the pregnant rat."Biopharm. Drug Dispos.. 19. 445-453 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] J. Nezu, I. Tamai, A. Oku, R. Ohashi, H. Yabuuchi, N. Hashimoto, H. Nikaido, Y. Sai, A. Koizumi, Y. Shoji, G. Takada, T. Matsuishi, M. Yoshino, H. Kato, T. Ohura, G. Tsujimoto, J. Hayakawa, M. Shimane and A. Tsuji.: "Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter."Nature Genet.. 21. 91-94 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Yokogawa, Y. Higashi, I. Tamai, M. Nomura, N. Hashimoto, H. Nikaido, J. Hayakawa, K. Mitamoto and A. Tsuji.: "Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice."J. Pharmacol. Exp. Ther.. 289. 224-230 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Yabuuchi, I. Tamai, J. Nezu, K. Sakamoto, A. Oku, M. Shimane, Y. Sai and A. Tsuji.: "Novel membrane transporter OCTN1 mediates multispecific, bidirectional and pH-dependent transport of organic cations."J. Pharmacol. Exp. Ther.. 289. 768-773 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Yokogawa, K. Miya, I. Tamai, Y. Higashi, M. Nomura, K. Miyamoto and A. Tsuji.: "Characteristics of L-carnitine transport in cultured hepatoma HLF cells from man."J. Pharm. Pharmacol.. 51. 935-940 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Yokogawa, M. Yonekawa, I. Tamai, R. Ohashi, Y. Tatsumi, Y. Higashi, M. Nomura, N. Hashimoto, H. Nikaido, J. Hayakawa, J. Nezu, A. Oku, M. Shimane, K. Miyamoto and A. Tsuji.: "Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice."Hepatology. 30. 997-1001 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] R. Ohashi, I. Tamai, H. Yabuuchi, J, Nezu, A. Oku, Y. Sai, M. Shimane and A. Tsuji.: "NaィイD1+ィエD1-dependent carnitine transport by OCTN2 and its pharmacological and toxicological relevance."J. Pharmacol. Exp. Ther.. 291. 778-784 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A. Koizumi, J. Nozaki, T. Ohura, T. Kayo, Y. Wada, J. Nezu, R. Ohashi, I. Tamai, Y. Shoji, G. Takada, S. Kibira, T. Matsuishi and A Tsuji.: "Genetic epidemiology on carnitine transporter OCTN2 gene in a Japanese population and phenotype characterizations in Japanese pedigrees with primary systemic carnitine deficiency."Human Molecular Genetics. 8. 2247-2254 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Murata, I. Tamai, Y. Sai, O. Nagata, H. Kato, Y. Sugiyama and A. Tsuji.: "Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent."J. Pharmacol. Exp. Ther.. 289. 79-84 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Sasabe, Y. Kato, T. Terasaki, A. Tsuji and Y. Sugiyama.: "Differences in the hepatobililary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat."Baiopharm. Drug Dispos.. 20. 151-158 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Murata, I. Tamai, H. Kato, O. Nagata, H. Kato and A. Tsuji.: "Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier."J. Pharmacol. Exp. Ther.. 290. 51-57 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Kawahara, A. Sakata, T. Miyashita, I. Tamai and A. Tsuji.: "Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice."J. Pharm. Sci.. 88. 1281-1287 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Yokogawa, M. Takahashi, I. Tamai, H. Konishi, M. Nomura, S. Moritani, K. Miyamoto and A. Tsuji.: "P-Glycoprotein-dependent disposition kinetics of tacrolimus : Studies in mdr1a knockout mice."Pharm. Res.. 16. 1213-1281 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y. Kido, I. Tamai, M. Okamoto, F. Suzuki and A. Tsuji.: "Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier of rats using in vitro cultured cells and in vivo BUI studies."Pharm. Res.. 17. 55-62 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Hirohashi, H. Suzuki, X.Y. Chu, I. Tamai, A. Tsujii and Y. Sugiyama.: "The function and expression of multidrug resistance-associated protein (MRP) family in human colon adenocarcinoma cells (Caco-2)."J. Pharmacol. Exp. Ther.. 292. 265-270 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi